Sec. 2. Authorization of use of drugs, vaccines, and medical technologies to expand military and civilian access to such products
256 words·~1 min read·
/bill/117/s/2486/is/section-2·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than one year after the date of the enactment of this Act, the Secretary of Defense shall submit to the Committees on Armed Services of the Senate and the House of Representatives a report on the efforts of the Secretary to comply with the paragraph entitled, Licensing of Federally owned medical interventions included on page 173 of the report of the Committee on Armed Services of the Senate to accompany the National Defense Authorization Act for Fiscal Year 2018 ( Public Law 115–91 ), which shall include the following information:
A description of what steps, if any, the Secretary has taken to comply with that paragraph. A complete list of the drugs, vaccines, and medical technologies that, as of the date of the enactment of this Act, meet the requirements outlined in that paragraph. For each drug, vaccine, or medical technology identified under paragraph (2), a discussion of the plans of the Secretary to utilize the authorities of the Secretary under section 203 or 209(d)(1) of title 35, United States Code, to authorize a third party or Federal agency to use the drug, vaccine, or medical technology.
Not later than one year after the date of the enactment of this Act, the Secretary of Defense, pursuant to section 203 or 209(d)(1) of title 35, United States Code, shall authorize third parties or Federal agencies to use not fewer than 10 drugs, vaccines, or medical technologies identified under subsection (a)(2) for the purpose of expanding military and civilian access to such drugs, vaccines, or technologies.
Connectionstraces to 1
Traces to 1 document
public-private-law
Citation graph
cites case law
Sec. 2
Authorization of use of drugs, vaccines, and medical technologies to expand military and civilian access to such products
Cites 1Cited by 0 across 0 sources